CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,801,000 | -43.5% | 4,035,344 | -14.5% | 0.00% | – |
| Q2 2022 | $8,499,000 | -57.9% | 4,722,217 | -52.7% | 0.00% | -100.0% |
| Q1 2022 | $20,172,000 | -23.5% | 9,985,759 | +2.6% | 0.00% | 0.0% |
| Q4 2021 | $26,374,000 | -37.7% | 9,732,570 | +2.5% | 0.00% | 0.0% |
| Q3 2021 | $42,347,000 | -17.2% | 9,495,073 | +7.7% | 0.00% | 0.0% |
| Q2 2021 | $51,131,000 | -6.8% | 8,815,674 | +12.7% | 0.00% | -50.0% |
| Q1 2021 | $54,890,000 | +67.0% | 7,819,010 | +14.2% | 0.00% | +100.0% |
| Q4 2020 | $32,860,000 | -5.4% | 6,845,807 | +14.9% | 0.00% | 0.0% |
| Q3 2020 | $34,724,000 | -8.5% | 5,956,075 | +5.9% | 0.00% | -50.0% |
| Q2 2020 | $37,961,000 | +57.4% | 5,624,008 | +48.3% | 0.00% | +100.0% |
| Q1 2020 | $24,115,000 | -32.3% | 3,791,837 | +10.9% | 0.00% | 0.0% |
| Q4 2019 | $35,643,000 | +86.0% | 3,419,068 | -29.9% | 0.00% | 0.0% |
| Q3 2019 | $19,158,000 | -71.7% | 4,874,868 | +7.2% | 0.00% | -66.7% |
| Q2 2019 | $67,649,000 | -36.3% | 4,549,310 | +6.4% | 0.00% | -40.0% |
| Q1 2019 | $106,127,000 | +35.8% | 4,275,846 | -1.7% | 0.01% | +25.0% |
| Q4 2018 | $78,130,000 | -38.3% | 4,350,158 | +0.9% | 0.00% | -20.0% |
| Q3 2018 | $126,642,000 | -35.7% | 4,311,940 | -0.4% | 0.01% | -44.4% |
| Q2 2018 | $196,873,000 | -1.0% | 4,329,743 | +15.0% | 0.01% | -10.0% |
| Q1 2018 | $198,877,000 | -21.5% | 3,766,622 | +1.1% | 0.01% | -16.7% |
| Q4 2017 | $253,392,000 | -14.5% | 3,726,359 | +3.6% | 0.01% | -20.0% |
| Q3 2017 | $296,370,000 | -6.8% | 3,596,716 | +5.9% | 0.02% | -11.8% |
| Q2 2017 | $318,039,000 | +63.8% | 3,396,752 | +11.4% | 0.02% | +54.5% |
| Q1 2017 | $194,174,000 | +170228.1% | 3,049,710 | +118797.1% | 0.01% | – |
| Q4 2016 | $114,000 | +10.7% | 2,565 | -10.8% | 0.00% | – |
| Q3 2016 | $103,000 | +194.3% | 2,875 | +12.4% | 0.00% | – |
| Q2 2016 | $35,000 | 0.0% | 2,557 | +40.9% | 0.00% | – |
| Q1 2016 | $35,000 | +20.7% | 1,815 | +121.6% | 0.00% | – |
| Q4 2015 | $29,000 | -63.8% | 819 | -7.0% | 0.00% | – |
| Q3 2015 | $80,000 | +42.9% | 881 | +38.5% | 0.00% | – |
| Q2 2015 | $56,000 | +14.3% | 636 | -3.5% | 0.00% | – |
| Q1 2015 | $49,000 | +16.7% | 659 | -12.7% | 0.00% | – |
| Q4 2014 | $42,000 | +23.5% | 755 | 0.0% | 0.00% | – |
| Q3 2014 | $34,000 | +6.2% | 755 | 0.0% | 0.00% | – |
| Q2 2014 | $32,000 | -28.9% | 755 | +16.7% | 0.00% | – |
| Q1 2014 | $45,000 | +25.0% | 647 | +6.8% | 0.00% | – |
| Q4 2013 | $36,000 | +5.9% | 606 | +7.3% | 0.00% | – |
| Q3 2013 | $34,000 | -81.5% | 565 | -79.5% | 0.00% | – |
| Q2 2013 | $184,000 | – | 2,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |